Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial

BACKGROUND: Palonosetron (Aloxi®, Onicit®) is a pharmacologically unique 5-HT(3) receptor antagonist (RA) approved as a single IV injection for the prevention of nausea and vomiting induced by chemotherapy (CINV) of either moderate or highly emetogenic potential (MEC and HEC, respectively). An oral...

Full description

Saved in:
Bibliographic Details
Main Authors: Boccia, Ralph, Grunberg, Steven, Franco-Gonzales, Edwin, Rubenstein, Edward, Voisin, Daniel
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2013
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612585/
https://ncbi.nlm.nih.gov/pubmed/23354552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-012-1691-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items